OPEN END-TURBO-OPTIONSSCHEIN - RESMED | Real-time Boerse Frankfurt Warrants 04:50:25 20/05/2024 pm IST | ||
| 3.69 EUR | +0.54% |
|
| Current month | +10.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 20/24/20 | 3.69 | +0.54% |
| 17/24/17 | 3.67 | -6.62% |
| 16/24/16 | 3.93 | +0.26% |
| 15/24/15 | 3.92 | +12.00% |
| 14/24/14 | 3.5 | -3.58% |
Real-time Boerse Frankfurt Warrants
Last update May 20, 2024 at 04:50 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | HSBC |
| WKN | HS6984 |
| ISIN | DE000HS69843 |
| Date issued | 26/04/2024 |
| Strike | 179.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.51 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.06 € |
|---|---|
| Lowest since issue | 2.36 € |
| Spread | 0.17 € |
| Spread % | 4.40% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
218.6
USD
Average target price
216.6
USD
Spread / Average Target
-0.88%
- Stock Market
- Certificates
- Certificat
